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Abstract
Background: The heart rate variability (HRV) analysis is a well-known method demonstrating its value over the years in different medical fields. However, 
it still has its known limitations. 
Material and methods: The new approach to HRV analysis is based on a complementary HRV standard analysis with new cardiophysiological biomarkers. 
The biomarkers are assessed on cardiorhythmograms obtained by a 5-minute ECG recording using a specialized hardware (Polyspectrum-HRV-device, 
Neurosoft). 
Results: A possible applicative value of the biomarkers is shown on examples of how a prognosis for recurrence of atrial fibrillation (AFib) could be made. 
When in a rest-state cardiorhythmogram are observed LF drops and are followed by a pathological counterregulation, prognostically, recurrence of atrial 
fibrillation is expected. When in a cardiorhythmogram LF drops are observed and are followed by a physiological counterregulation, prognostically, sinus 
rhythm is expected. Physiological background of the biomarkers: increased central modulation of the heart in rest state of a patient, a sympathetic overflow 
of the heart in calm state and insufficiency of compensatory parasymphatetic counteractivation. Limitations of the paper: this is a methodological paper 
without description of patients. This paper will be followed by a clinical paper in which we are going to describe the validation of these cardiophysiological 
biomarkers on patients with AFib. 
Conclusions: Complementary to the standard HRV analysis, cardiophysiological biomarkers should be assessed: LF drops and HF counterregulation 
could be used for prognosis construction in cardiology.
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Introduction
The new methodological approach described in this pa-
per is based on heart rate variability (HRV) analysis. The 
HRV analysis is a well-known method which has been 
demonstrating its value over the years in different medical 
fields [1, 27]. However, it still has its known limitations [2]. 
Although from a physiological point of view it could offer 
much more information than offer classical statistical pro-
grams for an automatic HRV analysis. One of the limita-
tions in use of HRV in the cardiologic field is the problem of 
steady-state cardiorhythmograms. Steady-state cardiorhyth-
mogram means, that during the 5-minute measurement no 
extra waves are triggered from outside or even inside, i.e. 
the person should demonstrate a constant breathing pattern 
without hyperventilation, no extrasystoles should occur nor 
any other arrhythmias and all other standard conditions [3] 
to avoid the appearance of extra waves, should be respected. 
As far as additional waves occur in the cardiorhythmogram, 
i.e. triggered by a change of respiratory pattern, extrasystoles 
etc., it cannot be analysed using classical methods of HRV 
analysis. Sometimes, such additional waves are cut out to 
make the classical analysis possible at all. However, cutting 
out, the biosignal loses some of its quality and reliability [4]. 
That is the main reason, why such cardiorhythmograms are 
mostly just ignored or just minimal information is extract-
ed from such a HRV analysis. For instance, to determine 
whether the HRV is high or low – from a physiological point 
of view – there is only a minimum of information that could 
be extracted from a HRV analysis when applying also physi-
ological skills for a HRV analysis. In cardiology, there are 
very common cardiorhythmograms which do not at all cor-
respond to a steady-state cardiorhythmogram. That is why 
in this field there are a lot of limitations in the application of 
HRV analysis. Mathematicians are trying to solve this prob-
lem by using an analysis of non-steady-state cardiorhyth-
mograms with non-linear methods of HRV analysis [5, 27, 
31]. Another possible way to solve this problem is described 
in this paper. It is proposed to assess the standard HRV 
analysis using additionally cardiophysiological biomarkers 
for a more advanced physiological HRV interpretation. 
Material and methods
The biomarkers are assessed on cardiorhythmograms 
obtained by a 5-minute ECG recording using a specialized 
hardware (Polyspectrum-HRV-device, Neurosoft). The bio-
signal was obtained from a one-channeled ECG, the first 
derivative was applied. It is important to mention, that the 
biosignal for further HRV analysis was obtained not from 
a Holter ECG. In order to obtain a reliable biosignal and to 
ensure the reproducibility of the data, all standard condi-
tions during measurement were regarded [3].
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Standard operating procedure for heart rate 
variability recording
Resting state probe includes a 5-minute ECG recording 
which is done in supine position. During the recording the 
person lies quietly but is alert with free spontaneous breath-
ing. The person has to be in sinus rhythm. Before start-
ing with the recording itself, a steady-state was achieved. 
Therefore, the person lies with connected electrodes and is 
checked on the monitor until the moment when a steady-
state signal is reached. Only then starts the recording of the 
ECG signal which will be used for further HRV analysis. 
The length of the transition phase needed for achieving a 
steady-state signal is very individual and usually takes from 
5 to 20 minutes [6]. This is to avoid false positive reactions 
of an increased level of the sympathetic or parasympathetic 
part of the vegetative nervous system. In the rest state probe, 
there should be an assessment of the functional activity of 
the regulatory systems of the heart including the medullar 
level and the central one. It can be concluded that a reliable 
and qualitative assessment can only be effected, if all addi-
tional influences, not belonging to the rest state condition, 
are excluded.
Results and discussion
The data were analysed by the use of „Neuro-Soft“-soft-
ware which is working with biosignals and is specialized on 
HRV analysis. Additionally the data were analysed by us-
ing cardiophysiological biomarkers. Standard HRV analysis 
methods are not described in this paper as these are well 
known [3, 12]. The new physiological approach to HRV 
analysis by using cardiophysiological biomarkers will be de-
scribed. These are applied when evaluating cardiorhythmo-
grams and spectrograms. Were applied several cardiophysi-
ological biomarkers but in this paper are described only the 
most informative, most important and most convenient 
ones for the data analysis: Low frequency (LF) drops, high 
frequency (HF) counterregulation and increased central ac-
tivity in rest state. 
HRV is applied for risk determination in different car-
diovascular diseases [5, 28]. In order to illustrate a possible 
way of applying cardiophysiological biomarkers, there are 
given examples of how a prognosis for atrial fibrillation and 
sinus rhythm can be made. Hence, we analysed different 
cardiorhythmograms and spectrograms using the cardio-
physiological biomarkers. 
Below are presented cardiorhythmograms and spectro-
grams, where prognostically a sinus rhythm (SR) is expect-
ed by applying the biomarkers’ analysis:
1.A. On the rhythmogram no LF drops are recognized and 
the HRV is predominantly modulated by HF waves (fig. 1).
1.B. On the spectrogram dominates the HF spectrum 
area (blue) with a physiological peaks’ distribution (fig. 2). 
2.A. On a rhythmogram LF drops are present but are 
followed by a physiological counterbalancing via HF waves 
(fig. 3).                                     






































































































Fig. 1.  Cardiorhythmograms without LF drops, HRV is modulated by HF waves. 
On the left side – rhythmogram of a younger person, on the right side – of an older person.
Fig. 2  Spectrograms belong to the rhythmograms above.  On both spectrograms a physiological peaks’ distribution is visible.























Fig. 3  Cardiorhythmogram. LF drops are present, but are 
followed by a physiological counterbalancing via HF waves.
2.B. The VLF component is increased on the spectrogram 
but the HF spectrum has a physiological HF peaks‘ distribu-
tion, sufficient to compensate the increased VLF component 
(fig. 4).                              






























Fig. 4  Spectrogram belonging to the rhythmgram above. VLF 
(green colour) is increased but the HF spectrum (blue colour) 























Fig. 5  Cardiorhythmogram. LF drops are absent but HRV is low 
and is in its modulation dominated by VLF and LF waves.
Below are presented cardiorhythmograms and spectro-
grams where prognostically AFib is expected by applying 
the biomarkers’ analysis:
1.A.  On a rhythmogram, even without LF drops, the 
HRV is low and is in its modulation dominated by VLF and 
LF waves (fig. 5).
1.B.  On a spectrogram the VLF component dominates 
in the total power spectrum. Pathological peaks’ structure 
in the HF spectrum area, representing parasympathetic 
break-down (fig. 6).






























Fig. 6  Spectrogram which belongs to the cardiorhythmogram 
above. VLF component dominates in the total power spectrum. 
Pathological peaks’ structure in the HF spectrum area, 
representing parasympathetic break-down.
2.A. On the rhythmogram LF drops are present, fol-
lowed by a pathological counterregulation: predominated 
























Fig. 7  Cardiorhythmogram. LF drops are present followed by a 
pathological counterregulation: predominated by LF waves.
2.B.  On the spectrogram (fig. 8) the VLF and LF com-
ponents are dominating in the total power spectrum and 
at the same time, there is evidence of a pathological peaks’ 
structure in the HF spectrum area, it means a parasympa-
thetic insufficiency, which is unable to compensate for the 
dominant VLF (central) component and increased LF com-
ponent (sympathetic overflow in calm state).
The HRV analysis with an additional application of bio-
markers, made on the figures above, requires a certain algo-
rithm.  Below is presented a simplified algorithm, which is 
proposed for the use by physicians in the daily practice but 
still should be validated clinically afterwards. It is based on 
cardiophysiological biomarkers described in this paper. The 
algorithm is used for the prognosis regarding sinus rhythm 
maintenance or AFib recurrence.
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1. In the rhythmogram:
– Are LF drops present or not?
– If there are no LF drops, it is necessary to assess: is the 
HRV high or low?
– If LF drops are present, it is necessary to assess: is it 
parasympathetic or sympathetic counterregulation?
2. In the spectrogram:
– Do the peaks in the HF spectrum have a physiological 
structure?
– Is the VLF component pathologically high in the whole 
spectrum or in the physiological normal range?
– Is there evidence of a VLF + LF coupling in the transi-
tion?
Risk stratification for AFib using the questions described 
above:
1. In the rhythmogram:
– If LF drops are absent and the HRV is high –the risk 
is low
– If LF drops are absent, but the HRV is low – the risk 
is high
– LF drops are present – it is a risk factor. Parasympa-
thetic counterregulation after LF drops – the risk is 
low, sympathetic counterregulation after LF drops –
the risk is high.
2. In the spectrogram:
– Peaks in the HF spectrum – in case of a physiologi-
cal structure: a main peak with two or three side peaks – 
the risk is low. Pathological peaks’ distribution in the HF 
spectrum: several main peaks / no major peak/ only low-
amplitude peaks scattered in the spectrum – the risk is high.
– VLF component: in case of a physiological VLF pro-
portion in the entire spectrum (not dominating over the HF 
and the LF components of the total spectrum) – low risk; if 
pathological (VLF component proportion in the total spec-
trum is increased and dominates over the HF and LF spec-
tra) – high risk.
– VLF + LF coupling in transition not present – low risk; 
VLF + LF coupling present in transition – high risk.
Below are given explanations on how to assess the car-
diorhythmograms and spectrograms illustrated in the text 
above. Also, it is described how the cardiophysiological bio-
markers are identified, by assessing a cardiorhythmogram 
or spectrogram and the physiological background of the 
cardiophysiological biomarkers.
Assessment of cardiorhythmogram
For a more convenient understanding of all cardiorhyth-
mograms in the paper, is given a brief explanation: on the 
abscissa there is the number of the R peaks deriving from 
ECG, marked by the letter “N”. On the ordinate is shown the 
beat-to-beat interval measured in seconds. 
Now the approach to the cardiorhythmogram analysis 
proposed in this paper: first of all, it is important to recog-
nize whether any LF drops in the cardiorhythmogram are 
present (what exactly is considered to be LF drops will be 
explained in detail later in the text). If there are no LF drops 
present, it means this is a steady-state cardiorhythmogram 
(fig. 9 and fig. 10), it can be analysed according to standard 
HRV analysis procedure [7]. According to the risk strati-
fication, there is a difference between the figure 9 and 10. 
The cardiorhythmogram represented on figure 9 reflects a 
low risk for developing AFib. For the risk stratification and 
prognosis it is important to recognize whether the HRV is 
modulated by the medullar or by the central level of heart 
regulation. This physiological background is seen on a car-
diorhythmogram recorded in calm state: when it is pre-
dominantly modulated by HF waves (fig. 9), then it can be 
assumed, that the parasympathetic nervous system works 
physiologically sound and the heart is regulated mainly by 























Fig. 9.  Cardiorhythmogram. In this cardiorhythmogram the HF 
waves dominate. There are no LF drops.
On the next figure (fig. 10) there is another extreme. 
There are still no LF drops present, but the HRV is modu-
lated predominantly by VLF and LF waves. From a physi-
ological point of view, this is a dangerous situation, because 
the heart is modulated in rest state not by the medullar level 
but mainly by the central level [8, 9, 24]. This supports that 
prognostically AFib is expected. 
However, examples presented on figure 9 and 10 repre-
sent two extreme cases, but there are fluent phases in be-
Fig. 8  Spectrogram which belongs to the cardiorhythmogram 
above.  VLF and the LF components are dominating in the 
total power spectrum.  Pathological peaks’ structure in the HF 
spectrum area.
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tween, when a prognosis cannot be made so obviously. That 
is why the use of cardiophysiological biomarkers, in order 
to apply them in addition to the standard HRV analysis, are 
proposed. On the next example (fig. 11) you can see a car-
diorhythmogram with LF drops. LF drops represent non-
steady-state events. As far as these are recognized, the HRV 
cannot be assessed by standard HRV analysis [3, 25]. How 
can it be analysed then? Assessing the LF drops as being one 
cardiophysiological biomarker and the HF counterregula-
tion as another one. What are the LF drops? LF drops are 
waves on a cardiorhythmogram, occurring suddenly at the 
end or in the middle of a VLF wave (fig. 11 LF drops are 
marked by red arrows). They drop down towards the beat-
to-beat interval shortening, that is why we called them LF 
drops, it means low frequency drops. Low frequency (LF) 
waves on a cardiorhythmogram are normally physiologi-
cally driven by sympathetic inputs [10]. But the difference 
between physiological LF waves and LF drops consists in a 
sudden appearance of sympathetic overflow represented by 
LF waves of high intensity on a rhythmogram. That is why 
we called them LF drops. Taking into account that these are 
rest-state cardiorhythmograms, it is a pathological condi-
tion. A sympathetic overflow of the heart in rest state it is 
observed, when the medullar heart modulation is working 
insufficiently, thus the central modulation of the heart in-
creases compensatory [8, 11]. Such a state destabilizes the 
heart rhythm [10, 26]. As a result, the appearance of LF 
drops on a cardiorhythmogram in rest state is connected 
with an increased risk for AFib.
As a second step of analysis of cardiorhythmograms with 
LF drops, the HF counterregulation should be assessed. The 
HF counterregulation is represented by the waves following 
the LF drops (fig. 11 encircled blue) in order to counterbal-
ance them [12]. Under physiological conditions it is expect-
ed that the counterbalancing reaction is to be ensured by 
a parasympathetic compensatory reaction [12]. In this case 
on cardiorhythmograms HF (high frequency) waves will be 
observed, which correspond to parasymphatetic modula-
tion of the heart. In case of a pathological counterregulation, 
LF waves will be seen. A pathological counterregulation is 
connected with a high risk for AFib recurrence. Figure 11 
represents an example of a pathological counterregulation. 
It is classified pathological, because it is ensured mainly by 
LF waves instead of HF waves. It takes place when the coun-
terregulation after LF drops is exerted not by the medullar 
level of heart regulation, but predominantly, by the central 
level [8, 14, 32]. In other words, the parasymphatetic activity 
is responding not effectively enough in reacting to sympa-
thetic activations driven by the increased central regulatory 
activity in calm state. It is a parasympathetic break-down 
reaction during answering to LF drops (fig. 11 blue arrow). 
This is connected with a high risk for AFib recurrence.
LF drops followed by a pathological counterregulation 
can occur not only on cardiorhythmograms with a low HRV 
(fig. 11) but they also occur often on cardiorhythmograms 
with a high HRV (fig. 12). 
Fig. 12  Cardiorhythmogram. LF drop (encircled red) followed 
by a pathological counterregulation (blue frame): predominantly 
modulated by LF waves, instead of HF waves and with a drop-
down of waves during counterbalancing.
Fig. 10.  Cardiorhythmogram. HRV is modulated predominantly 























Fig. 11  Cardiorhythmogram. The heart regulation is 
predominantly ensured by the central level: LF drops are marked 
with red arrows. The counterbalancing waves (encircled blue) 
are present predominantly by LF waves instead of HF waves. 
A parasympathetic break-down (blue arrow) reaction, when 
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On figure 12 you can see the LF drop (encircled red) fol-
lowed by a pathological counterregulation (blue frame). On 
this cardiorhythmogram the HRV is high, but if you look at 
the counterregulation, you can recognize, that it is ensured 
mainly by LF waves. It means, that the parasymphatetic 
counteractivity is functionally not sufficient to compensate 
for sympathetic central activity in calm state [15, 32]. This is 
connected with a high risk for AFib recurrence.
Below, there is an example of a cardiorhythmogram, 
where the LF drops are present, meaning an increased cen-
tral modulation, but the counterregulation is modulated 
by HF waves (fig. 13). That means, the parasymphatetic 
counterbalancing activity is sufficient to compensate for an 
increased central modulation of the heart in calm state. In 























Fig. 13.  Cardiorhythmogram. LF drops between beat-to-beat 
interval 40 – 50, 90 – 100, 170 – 180 (abscissa), followed by a 
counterregulation by HF waves.
In addition to the rhythmograms, the corresponding 
spectrograms can also be assessed. On the spectrograms it 
is also possible to apply the physiological background of the 
cardiophysiological biomarkers. The influence of the central 
heart modulation can be analyzed by the VLF component 
and the vagal activity can be analyzed by the HF spectrum 
(more in detail in the following text).
Assessment of the spectrogram
For a more convenient assessment of spectrograms it 
should be briefly noted what is shown on the abscissa and 
ordinate. On the abscissa you can see three groups of fre-
quencies (obtained from cardiorhythmograms) in Hertz 
[16]. Marked by blue colour is the HF – high frequency 
spectrum area, which represents the parasympathetic part 
of the vegetative nervous system. By the red colour the low 
frequency (LF) spectrum area is marked, which represents 
the influence of the sympathetic part of the vegetative ner-
vous system, acting by noradrenaline. The green colour in 
the spectrogram represents the VLF component of the spec-
trum. It is the very low frequency component. It represents 
the central modulation of the heart (cortex, limbic system, 
hypothalamus) [8, 9, 32]. Important to mention as well is 
that the VLF component represents the central heart modu-
lation in case of a rest-state probe in 5-minute ECG record-
ings under steady-state conditions [8, 17]. In case of HRV 
analysis from a Holter ECG, the VLF component has other 
characteristics and origin, it does not represent the central 
modulation of the heart. These three groups of frequencies 
are measured in Hertz in the spectrogram. All these three 
spectra make up the total power spectrum in amplitudes, 
which is represented on the y-axis.
When assessing the spectrogram, it is important to note 
what the spectral distribution looks like and what propor-
tion of each spectrum is in the overall spectrum. First, the 
peaks’ distribution in the HF area is considered: if a main 
peak is observed and accompanied side by side by one or 
two smaller secondary peaks (they should be half-sized or 
one quarter of the size of the main peak), then it is assumed 
that the parasympathetic heart modulation physiologically 
works well and a sinus rhythm is most probably predicted 
(fig. 14).




























Fig. 14.  Spectrogram. Physiological HF peaks’ distribution: 
there is the main peak on frequency about 0.2 Hz (abscissa) 
 and laterally smaller side peaks are seen.
It should be noted that the distribution of the peaks on 
the frequencies depends on the individual respiratory rate 
[18, 30]. The closer the main peak is to 0.4 Hz (see abscissa 
fig. 14), the higher the respiratory rate. The closer the main 
peak shifts in the opposite direction, closer to the green spec-
trum area, the slower the person’s breathing. As can be seen 
(fig. 14), the main peak is at the frequency value 0.2. Thus, 
the respiratory rate is about 10 breath cycles per minute. 
In spectral analysis it is also important to estimate the 
VLF component. This gives information about the central 
input of the VNS in the cardiac regulation. [17]. Under phys-
iological conditions predominantly the medullar level mod-
ulates the heart at rest [8, 9] (fig. 14), opposite to the central 
level (VLF area). In the spectrogram you can see it well: the 
majority is made up of the blue and the red spectra. How-
ever, the green portion does not dominate over the blue and 
the red spectra. Under these circumstances we expect a SR.
In pathological situations, when a dominant green spec-
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trum area on a spectrogram (fig. 15) during rest-state probe 
is observed, it is considered that the central level of heart 
modulation is more involved than the medullar one. This 
is a dangerous state from a physiological point of view [19, 
29], as it represents risk factors for the development of AFib. 






























Fig. 15.  Spectrogram. Pathological regulation of the heart:  
an increased central modulation – VLF (green) component in 
the total power spectrum and a pathological – HF spectrum area 
(blue) – a parasympathetic break-down.
On the next spectrogram (fig. 16) you can see an in-
creased VLF spectrum (green) followed by a marked in-
creased LF spectrum (red). That means, an increased central 
modulation of the heart parallel with an increased sympa-
thetic overflow [20, 21, 32] of the heart. It is important to 
keep in mind, that it was a rest-state ECG registration, so it 
is an increased sympathicotonia in calm state. In such con-
ditions, it is important to have an effective vagal compensa-
tion [8, 31]. But if you look at (fig. 16) the HF spectrum 
(blue) corresponding to the parasympathetic functional 
activity, you recognize a lack of functional parasympathetic 
activity. In the blue spectrum there is a pathological wave 
distribution: only one peak without side peaks, instead there 
are very low amplitude peaks distributed through the whole 
HF spectrum area. It is obvious, that such a vagal counter-
balance is not able to compensate effectively enough such 
a high central modulation and sympathetic overactivity of 
the heart [23, 31]. This represents a parasympathetic insuffi-
ciency, so the vagus is able to counterbalance only for short-
term reactions but is not able to fulfill effectively enough 
its counterregulatory function against sympathetic central 
overflow. Hence, prognostically, AFib is expected.
It is important to note, that in case the VLF component 
is increased in the total power spectrum, the HF component 
should also be assessed in order to make a correct qualitative 
prognosis. When VLF is increased, but the HF spectrum has 
a physiological peaks’ distribution, it can be concluded that 
the parasympathetic functional activity is sufficient in order 
to compensate for an increased central input to the heart in 
rest state (fig. 17) [32]. 






























Fig. 17.  Spectrogram. Increased VLF in the total power 
spectrum compensated by a physiological HF spectrum.
Conclusions
1. In addition to the standard HRV analysis, cardiophys-
iological biomarkers should be assessed: LF drops and HF 
counterregulation. On the example of prognosis construc-
tion for atrial fibrillation based on the biomarkers a possible 
applicative value of them is explained.
2. When in a steady-state cardiorhythmogram LF drops 
are observed followed by a pathological counterregulation, 
prognostically atrial fibrillation recurrence is expected.
3. When in a steady-state cardiorhythmogram LF drops 
are observed followed by a physiological counterregulation, 
prognostically, sinus rhythm is expected.
4.  Additionally to the cardiorhythmogram the biomark-
ers can be assessed in a spectrogram using the VLF and the 
HF components.
5. When the VLF component is pathologically high in 
rest state and the structure of the HF spectrum is patho-
logical, prognostically the recurrence of atrial fibrillation is 
expected.
6. When the VLF component is pathologically high in 
rest state but the structure of the HF spectrum is physiologi-
cal, prognostically sinus rhythm is expected.
7. Physiological background of the biomarkers: increased 




































Fig. 16.  Spectrogram. Increased VLF component (green)  
in the total power spectrum and a marked high LF component 
(red). HF spectrum area: only one main peak without side 
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central modulation of the heart in rest state (LF drops pres-
ent, increased VLF) is a risk factor for atrial fibrillation but if 
the parasymphatetic modulation is sufficient to compensate 
for it (HF counterregulation by HF waves, physiological HF 
spectrum), sinus rhythm is expected. If the parasympathetic 
modulation is not sufficient to compensate for it (counter-
regulation by LF waves, pathological HF spectrum), atrial 
fibrillation is expected.
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